Are you a healthcare professional? Join GoodRx for HCPs

Otezla

Apremilast

Switch to generic medication

Medicare Drug Info Learn about brand-name medications Side Effects Dosage

Explore Otezla infoSponsored

About Otezla

Otezla (apremilast) is used to treat psoriasis and psoriatic arthritis. Otezla is a PDE4 Inhibitor, which works by reducing inflammation in the lungs. The most common form of Otezla is a 30mg tablet. It's also available in titration packs. It is available in both generic and brand versions. It is covered by some Medicare and insurance plans, but some pharmacy coupons or cash prices may be lower.

With the Patient Assistance Program from PAN Foundation, contact the program to see how they can financially help you out.

Other PDE4 Inhibitors

Related conditions

Plaque Psoriasis

Psoriatic Arthritis

Browse medications

View All

Research prescriptions and over-the-counter medications from A to Z, compare drug prices, and start saving.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Enroll Now

Requires private insurance

No matter your current financial situation, we are here to help YOU.

The Otezla Co-Pay Program is designed to help eligible patients with commercial insurance (usually self-purchased or through an employer) lower their out-of-pocket costs for Otezla.

*Eligibility criteria and program maximums apply. See AmgenSupportPlus.com/copay-terms for full Terms and Conditions.

Terms and Conditions Prescribing Information

USA-407-83667

Sponsored by

Important Safety Information

You must not take Otezla if you are allergic to apremilast or to any of the ingredients in Otezla.

Otezla can cause allergic reactions, sometimes severe. Stop using Otezla and call your healthcare provider or seek emergency help right away if you develop any of the following symptoms of a serious allergic reaction: trouble breathing or swallowing, raised bumps (hives), rash or itching, swelling of the face, lips, tongue, throat or arms.

Otezla can cause severe diarrhea, nausea, and vomiting, especially within the first few weeks of treatment. Use in elderly patients and the use of certain medications with Otezla appears to increase the risk of complications from having severe diarrhea, nausea, or vomiting. Tell your doctor if any of these conditions occur.

Otezla is associated with an increase in depression. In clinical studies, some patients reported depression, or suicidal behavior while taking Otezla. Some patients stopped taking Otezla due to depression. Before starting Otezla, tell your doctor if you have had feelings of depression, or suicidal thoughts or behavior. Be sure to tell your doctor if any of these symptoms or other mood changes develop or worsen during treatment with Otezla.

Some patients taking Otezla lost body weight. Your doctor should monitor your weight regularly. If unexplained or significant weight loss occurs, your doctor will decide if you should continue taking Otezla.

Some medicines may make Otezla less effective and should not be taken with Otezla. Tell your doctor about all the medicines you take, including prescription and nonprescription medicines.

The most common side effects of Otezla include diarrhea, nausea, upper respiratory tract infection, tension headache, and headache. These are not all the possible side effects with Otezla. Ask your doctor about other potential side effects. Tell your doctor about any side effect that bothers you or does not go away.

Tell your doctor if you are pregnant, planning to become pregnant or planning to breastfeed.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-332-1088.

Please click here for the Full Prescribing Information for Otezla.

APPROVED USES

Otezla® (apremilast) is a prescription medicine used to treat adult patients with:

Plaque psoriasis for whom phototherapy or systemic therapy is appropriate.
Active psoriatic arthritis.
Oral ulcers associated with Behçet’s Disease.

Otezla

About Otezla

Other PDE4 Inhibitors

Related conditions

Browse medications

Good news for your inbox

Generic Alternative Available

Patient Assistance Program from Amgen

Patient Assistance Program from PAN Foundation